Fire needle acupuncture or moxibustion for chronic plaque psoriasis: study protocol for a randomized controlled trial

This is not the most recent version of this document

View the latest version

Authors
Category Primary study
Pre-printResearchSquare
Year 2019
Background: Psoriasis is a chronic, immune-mediated disorder with chronic plaque psoriasis during remission stage. Patients often have a slow course and long history of the disease. The refractory type of psoriasis is a stubborn rash that does not subside easily. We designed this randomized controlled trial to compare the effectiveness and relapse rates of plaque psoriasis in patients treated with either acupuncture, moxibustion or calcipotriol ointment. The ultimate aim of the study is to select an effective traditional Chinese medicine (TCM) clinical program for patients with plaque psoriasis. Methods: The study will be a multi-center, prospective randomized controlled trial (RCT), which compares the effectiveness of fire needle therapy, moxibustion and calcipotriol ointment. A total of 160 plaque psoriasis patients will be recruited and randomly assigned to receive either fire needle therapy (group A1), moxibustion (group A2) or calcipotriol ointment (group B). All participants will receive a 8-week treatment and then be followed up for another 24 weeks. The primary outcomes measured are relapse rates and Psoriasis area and severity index (PASI) score of the target lesions. The secondary outcomes are target lesion onset time, area and severity score. In addition, the overall clinical cure and improvement rate, dermatology life quality index (DLQI), TCM syndrome score, target recurrence rate and interval of the target lesion will be measured. Discussion: This study is to determine whether fire needle therapy or moxibustion could improve the clinical effectiveness of psoriasis lesions and reduce the relapse rate. Once completed, it will provide information regarding therapeutic evaluation on fire needle therapy or moxibustion for plaque psoriasis, which will assist clinicians select the most effective treatment options for patients. Trial registration: ChiCTR1800019588; Pre-results; Registered on 19 November 2018; International Clinical Trials Registry Platform (ICTRP). URL: http://apps.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800019588 Keywords: Fire needle therapy, Moxibustion, Plaque Psoriasis, Clinical effectiveness, Relapse rate
Epistemonikos ID: dfe27bc3f963f1d893757c24873c5f123ddcf7b1
First added on: Jan 26, 2021